The forecasts indicate a steady state in the number of stem cell transplantations performed as inpatient cases in France from 2024 through 2028, with each year holding at a consistent value of 92.7. When looking at 2023, the actual number of inpatient stem cell transplants provides a crucial baseline; however, without explicit data from 2023 in the dataset, no year-on-year variation is calculated. The lack of significant change over multiple years, reflected by a CAGR of 0%, suggests stabilization in procedures.
Future trends to watch include advancements in stem cell technology that may lead to alternative treatments and changes in hospital policies and funding that could influence the demand and supply balance for stem cell transplants in the upcoming years.
